Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Pancreatic Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Very early researchUnknownNCT05287165
What this trial is testing

Clinical Trial to Evaluate the Safety and Efficacy of IM96 CAR-T Cells Therapy in Patients With Advanced Digestive System Neoplasms

Who this might be right for
Advanced Solid TumorsDigestive System NeoplasmsPancreatic Cancer Resectable+1 more
Beijing Immunochina Medical Science & Technology Co., Ltd. 19
Early research (Phase 1)Study completedNCT04634539
What this trial is testing

Trial of First-line L-glutamine With Gemcitabine and Nab-paclitaxel in Advanced Pancreatic Cancer

Who this might be right for
Advanced Pancreatic AdenocarcinomaPancreatic CancerPancreatic Ductal Adenocarcinoma
Jun Gong, MD 18
Early research (Phase 1)Study completedNCT03095781
What this trial is testing

Pembrolizumab and XL888 in Patients With Advanced Gastrointestinal Cancer

Who this might be right for
Colorectal AdenocarcinomaMetastatic Pancreatic AdenocarcinomaRecurrent Colorectal Carcinoma+12 more
Emory University 47
Testing effectiveness (Phase 2)Study completedNCT04247165
What this trial is testing

Nivolumab, Ipilimumab and Chemoradiation in Pancreatic Cancer.

Who this might be right for
Borderline Resectable, Locally Advanced or Metastatic Pancreatic Cancer
Herlev Hospital 55
Testing effectiveness (Phase 2)UnknownNCT03139487
What this trial is testing

Phase II Open Label Study to Compare the Safety and Efficacy of Subcutaneous Dalteparin Versus Direct Oral Anticoagulants for Cancer-associated Venous Thromboembolism

Who this might be right for
Cancer-associated ThrombosisEsophageal CancerStomach Cancer+7 more
Asan Medical Center 176
Testing effectiveness (Phase 2)Active Not RecruitingNCT06105021
What this trial is testing

Phase I Study of Autologous CD8+ and CD4+ Engineered T Cell Receptor T Cells in Subjects With Advanced or Metastatic Solid Tumor

Who this might be right for
Pancreatic Ductal AdenocarcinomaNon-Small Cell Lung CancerColorectal Cancer+2 more
Affini-T Therapeutics, Inc. 100
Testing effectiveness (Phase 2)Study completedNCT00560963
What this trial is testing

Treatment of Patients Suffering From a Progressive Pancreas Carcinoma With Everolimus (RAD001) and Gemcitabine

Who this might be right for
Advanced or Metastatic Pancreatic Adenocarcinoma
Novartis Pharmaceuticals 21
Testing effectiveness (Phase 2)Study completedNCT03807999
What this trial is testing

Nab-Paclitaxel Plus Gemcitabine Versus Gemcitabine For The First Line Treatment of Pancreas Cancer

Who this might be right for
Pancreatic Neoplasm
Hacettepe University 125
Testing effectiveness (Phase 2)Ended earlyNCT02202785
What this trial is testing

MLN0264 in Patients With Pancreatic Cancer

Who this might be right for
Pancreatic Adenocarcinoma
Millennium Pharmaceuticals, Inc. 43
Testing effectiveness (Phase 2)UnknownNCT05298020
What this trial is testing

Envafolimab Combined With Endostar and Chemotherapy for First-line Treatment of Advanced Pancreatic Cancer

Who this might be right for
Advanced Pancreatic Cancer
The Affiliated Hospital of Xuzhou Medical University 20
Early research (Phase 1)Study completedNCT01155258
What this trial is testing

Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid Tumors

Who this might be right for
Extensive Stage Small Cell Lung CancerHereditary ParagangliomaMale Breast Cancer+45 more
University of Southern California 19
Early research (Phase 1)Temporarily pausedNCT07173374
What this trial is testing

Stereotactic Centralized Ablative Radiotherapy for Locally Advanced Pancreatic Cancer: A Single-Arm Phase I Safety and Feasibility Study

Who this might be right for
Pancreatic CancerLocally Advanced Pancreatic Cancer
Shandong Cancer Hospital and Institute 24
Early research (Phase 1)Active Not RecruitingNCT03875820
What this trial is testing

Phase I Trial of Defactinib and VS-6766.

Who this might be right for
NSCLCLow Grade Serous Ovarian CancerEndometrioid Carcinoma+1 more
Institute of Cancer Research, United Kingdom 87
Testing effectiveness (Phase 2)Study completedNCT02210559
What this trial is testing

Gemcitabine Plus Nab-paclitaxel With or Without FG-3019 in Participants With Locally Advanced, Unresectable Pancreatic Cancer

Who this might be right for
Pancreatic Cancer (Unresectable)
Kyntra Bio 37
Early research (Phase 1)Ended earlyNCT03825289
What this trial is testing

Trametinib and Hydroxychloroquine in Treating Patients With Pancreatic Cancer

Who this might be right for
Metastatic Pancreatic CarcinomaStage II Pancreatic CancerStage IIA Pancreatic Cancer+4 more
University of Utah 25
Testing effectiveness (Phase 2)UnknownNCT03636308
What this trial is testing

Nab-paclitaxel Plus S-1(AS) Versus Nab-paclitaxel Plus Gemcitabine(AG) in Patients With Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Peking University 40
Testing effectiveness (Phase 2)UnknownNCT06078787
What this trial is testing

Olaparib in PALB2 Advanced Pancreatic Cancer

Who this might be right for
Advanced Pancreatic CancerMetastatic Pancreatic Cancer
Azienda Ospedaliero-Universitaria di Modena 16
Early research (Phase 1)Study completedNCT00001431
What this trial is testing

A Phase I Trial of Gemcitabine and Radiation in Locally Advanced Unresectable Cancer of the Pancreas

Who this might be right for
Gastrointestinal NeoplasmsPancreatic Neoplasms
National Cancer Institute (NCI) 20
Large-scale testing (Phase 3)Ended earlyNCT00227617
What this trial is testing

Combination Chemotherapy and Bevacizumab in Treating Patients With Advanced Neuroendocrine Tumors

Who this might be right for
Gastrointestinal Carcinoid TumorIslet Cell TumorLung Cancer+2 more
University of California, San Francisco 36
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06531291
What this trial is testing

Surufatinib Combined With Serplulimab and Standard Chemotherapy as First-line Treatment in Advanced Solid Tumors With Neuroendocrine Differentiation

Who this might be right for
ESCCBiliary Tract CancerGastric Cancer+1 more
RenJi Hospital 80
Next Page